| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| accounting fees | 5,350 |
| Contractor | Explanation |
|---|---|
| DCF Capital | Management fees |
| Description of Property | Date Acquired | Cost or Other Basis | Prior Years' Depreciation | Computation Method | Rate / Life (# of years) |
Current Year's Depreciation Expense | Net Investment Income | Adjusted Net Income | Cost of Goods Sold Not Included |
|---|
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| NORSE ENERGY CORP 8.50% - 4059 | ||
| CNECN 8.000000% 06/30/2015 - 2 | 20,241 | 20,415 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| ALKERMES PLC - 2000 shs | ||
| ASTRAZENECA PLC- 1000 SHS | 0 | 0 |
| ASTRAZENECA PLC - 500 SHS | 0 | 0 |
| BIOGEN IDEC INC - 100 SHS | 0 | 0 |
| BRISTOL-MYERS SQUIBB- 1100 SHS | 0 | 0 |
| BRISTOL-MYERS SQUIBB- 500 SHS | 0 | 0 |
| CELANESE COR-SERIES A-1000 SHS | 0 | 0 |
| CELANESE COR-SERIES A-500 SHS | 0 | 0 |
| CELLDEX THERAPEUT INC-1000 SHS | 5,494 | 16,750 |
| CELLDEX THERAPEUT INC-1000 SHS | 6,743 | 16,750 |
| CELLDEX THERAPEUT INC-1500 SHS | 6,760 | 25,125 |
| CELLDEX THERAPEUT INC-1500 SHS | 5,726 | 25,125 |
| CELLDEX THERAPEUT INC-200 SHS | 1,666 | 3,350 |
| CELLDEX THERAPEUT INC-2000 SHS | 9,790 | 33,500 |
| CELLDEX THERAPEUT INC-2000 SHS | 10,489 | 33,500 |
| CELLDEX THERAPEUT INC-3500 SHS | 17,247 | 58,625 |
| CELLDEX THERAPEUT INC-3500 SHS | 19,490 | 58,625 |
| CUMMINS INC - 500 SHS | 0 | 0 |
| DOW CHEMICAL - 2000 SHS | 0 | 0 |
| ENDOCYTE INC - 600 SHS | 0 | 0 |
| FORD MOTOR CO - 2000 SHS | 0 | 0 |
| FORD MOTOR CO - 2000 SHS | 0 | 0 |
| FORD MOTOR CO - 3000 SHS | 0 | 0 |
| FORD MOTOR CO - 3000 SHS | 0 | 0 |
| FORD MOTOR CO - 5000 SHS | 0 | 0 |
| HONEYWELL INTL INC-100 SHS | 0 | 0 |
| HONEYWELL INTL INC-1000 SHS | 0 | 0 |
| HONEYWELL INTL INC-500 SHS | 0 | 0 |
| INCYTE CORP - 1000 SHS | 0 | 0 |
| INCYTE CORP - 200 SHS | 0 | 0 |
| INCYTE CORP - 3700 SHS | 30,255 | 248,122 |
| INCYTE CORP - 200 SHS | 3,270 | 13,412 |
| JOHNSON&JOHNSON - 1000 SHS | 67,570 | 107,780 |
| MONSANTO CO - 500 SHS | 0 | 0 |
| MONSANTO CO - 500 SHS | 0 | 0 |
| MONSANTO CO - 500 SHS | 28,209 | 57,520 |
| NEKTAR THERAPEUTICS - 200 SHS | 0 | 0 |
| NEKTAR THERAPEUTICS - 3000 SHS | 0 | 0 |
| NEKTAR THERAPEUTICS - 800 SHS | 0 | 0 |
| PACIRA PHARMACEUT INC-1000 SHS | 0 | 0 |
| PAN ORIENT ENERG CORP-5250 SHS | 0 | 0 |
| PFIZER INC - 1000 SHS | 0 | 0 |
| PFIZER INC - 1300 SHS | 0 | 0 |
| PFIZER INC - 700 SHS | 0 | 0 |
| PHARMACYCLICS INC - 1500 SHS | 0 | 0 |
| PRAXAIR INC - 500 SHS | 0 | 0 |
| PRAXAIR INC - 500 SHS | 0 | 0 |
| REGENERON PHARMA - 200 SHS | 0 | 0 |
| REGENERON PHARMA - 200 SHS | 0 | 0 |
| REGENERON PHARMA - 300 SHS | 0 | 0 |
| SANGAMO BIOSCIENC INC-3000 SHS | 0 | 0 |
| SANOFI-AVENTIS-ADR-1000 SHS | 0 | 0 |
| SANOFI-AVENTIS-ADR-1000 SHS | 0 | 0 |
| ISHARES RUSSELL 2000- 1000 SHS | 111,116 | 116,560 |
| MEDIVATION INC - 200 SHS | 18,907 | 21,140 |
| MEDIVATION INC - 100 SHS | 9,525 | 10,570 |
| ITCI INC - 500 SHS | 7,513 | 7,750 |
| ITCI INC - 1000 SHS | 17,039 | 15,500 |
| ITCI INC - 1000 SHS | 19,528 | 15,500 |
| ITCI INC - 500 SHS | 8,257 | 7,750 |
| ITCI INC - 400 SHS | 6,120 | 6,200 |
| ITCI INC - 100 SHS | 1,704 | 1,550 |
| MERCK & CO. INC - 500 SHS | 28,204 | 28,970 |
| PROOFPOINT INC - 100 SHS | 3,441 | 4,404 |
| PCRX INC - 100 SHS | 6,742 | 9,282 |
| PHARMACEUTICALS - 100 SHS | 13,568 | 39,372 |
| PAN ORIENT ENERGY CORP-800 SHS | 1,579 | 1,086 |
| SANGAMO BIOSCIENC INC-1000 SHS | 5,308 | 12,140 |
| PCRX INC - 200 SHS | 14,540 | 18,564 |
| NEKTAR THERAPEUTICS - 2000 SHS | 25,850 | 27,580 |
| MERCK & CO. INC - 500 SHS | 28,010 | 28,970 |
| NEKTAR THERAPEUTICS - 3000 SHS | 36,750 | 41,370 |
| PCRX INC - 500 SHS | 32,500 | 46,410 |
| PCRX INC - 200 SHS | 13,704 | 18,564 |
| BIOGEN IDEC INC - 100 SHS | 23,020 | 32,108 |
| ACTAVIS INC - 100 SHS | 21,571 | 24,274 |
| PAN ORIENT ENERG CORP-4250 SHS | 7,626 | 5,772 |
| BRISTOL MYERS SQUIBB - 600 SHS | 30,313 | 34,914 |
| GILEAD SCIENCES INC - 200 SHS | 16,313 | 22,400 |
| GILEAD SCIENCES INC - 400 SHS | 32,986 | 44,800 |
| GILEAD SCIENCES INC - 400 SHS | 32,712 | 44,800 |
| HON INC - 1000 SHS | 44,230 | 96,120 |
| HON INC - 300 SHS | 13,317 | 28,836 |
| GENERAL ELECTRIC CO - 1000 SHS | 26,930 | 25,810 |
| DOW CHEMICAL - 1000 SHS | 35,432 | 49,400 |
| GENERAL ELECTRIC C0 - 1000 SHS | 26,125 | 25,810 |
| GENERAL ELECTRIC CO - 1000 SHS | 26,457 | 25,810 |
| GENERAL ELECTRIC CO - 1000 SHS | 26,860 | 25,810 |
| Category/ Item | Cost/Other Basis | Accumulated Depreciation | Book Value | End of Year Fair Market Value |
|---|
| Category / Item | Cost / Other Basis | Accumulated Depreciation | Book Value | End of Year Fair Market Value |
|---|
| Description | Amount |
|---|---|
| PY ADJUSTMENT | 114 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| citibank - service charges | 30 | 30 | ||
| GAIN/LOSS FROM CURRENCY USE | 56 | 56 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| Jefferies - Other Income | 673 |
| Description | Beginning of Year - Book Value | End of Year - Book Value |
|---|---|---|
| SHORT POSITIONS |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| portfolio management fees | 53,104 | 53,104 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Federal Tax | 1,134 |